Assuntos
Hanseníase/complicações , Deformidades Adquiridas Nasais/etiologia , Doenças Nasais/etiologia , Adolescente , Adulto , Idoso , Animais , Criança , Pré-Escolar , Cães , Epistaxe/fisiopatologia , Feminino , Humanos , Lactente , Hanseníase/epidemiologia , Masculino , Pessoa de Meia-Idade , Mycobacterium leprae , Cavidade Nasal/fisiopatologia , Mucosa Nasal/fisiopatologia , Septo Nasal/fisiopatologia , Deformidades Adquiridas Nasais/epidemiologia , Doenças Nasais/epidemiologia , Mucosa Olfatória , Conchas Nasais/fisiopatologiaRESUMO
PIP: Semen analysis was performed on 8 men, every 2 months, for a period of 8 months, after the application of the radiozinc spermatogensis test. Semen was examined for volume, cell count, motility, and abnormal forms. Results showed no evidence of any changes in semen parameters. Student's test was used to compare the data before the test with the data after the test, and no significant differences were seen. The radiozinc spermatogensis test seems safe, from a radiologic point of view, does not have an adverse effect on semen, and unlike testicular biopsy, saves the patient from surgical exposure. The radiozinc spermatogensis test can be applied as an important adjuvant measure in the diagnosis and prognosis of male infertility.^ieng
